Page last updated: 2024-08-24

halofuginone and Esophageal Neoplasms

halofuginone has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lu, H; Wang, Y; Xie, Z	1

Other Studies

1 other study(ies) available for halofuginone and Esophageal Neoplasms

Article	Year
RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. Life sciences, 2020, 09-15, Volume: 257 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Esophageal Neoplasms; Forkhead Box Protein O3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Piperidines; Quinazolinones; Signal Transduction	2020

Article

Year

RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway.

Life sciences, 2020, 09-15, Volume: 257

Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Esophageal Neoplasms; Forkhead Box Protein O3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Piperidines; Quinazolinones; Signal Transduction

2020